|
|
Post by gwb on Dec 12, 2015 0:13:15 GMT -5
www.clickorlando.com/news/new-drug-may-help-some-diabetes-patients
An estimated 29 million Americans are living with diabetes, a chronic disease that can be both debilitating and deadly.
But now, there's a new form of insulin that's helping some people manage the most difficult aspects of the disease.
[WEB EXTRA: Learn more about Afrezza]
Sam Finta is one of those people. He has always been fit and considered himself healthy. But everything changed with a diagnosis of type one diabetes in 1999.
"It's a life long disease and you have to manage it several hours a day," said Finta.
But that all changed when he became part of a clinical trial for a powdered form of insulin called Afrezza. Rather than pumps and injections, the drug comes in a little whistle like device that is inhaled just before mealtime.
"It's a major breakthrough as far as i'm concerned because it's a very innovative drug," said podiatrist Dr. Eric Weinstein.
He deals with one of the main complications of diabetes, neuropathy---or nerve damage---that leads to foot ulcers that won't heal.
Weinstein said Afrezza could be a game changer for people with both type one and two diabetes.
"Not only is it not only is it the convenience factor but it's also quick acting so it's in and out of your system very fast," said Weinstein.
That means patients can avoid the problematic blood sugar highs and lows that come with typical treatment.
"Until Afrezza, I didn't realize how sick I've been because I've normalized my blood sugar, before dealing with highs and lows and as a diabetic, I get used to it," said Finta.
Finta is planning a walk from Miami to Jacksonville to spread the word.
"I always thought that I was going to be the youngest person to die in my family, but now I have the hope of living a full healthy life," said Finta.
The only potential contraindication with Afrezza - because it's an inhaled powder, it cannot be used by people with long term, chronic lung disease.
Copyright 2015 by WKMG ClickOrlando - All rights reserved.
www.clickorlando.com/news/new-drug-may-help-some-diabetes-patients
|
|
|
|
Post by compound26 on Dec 12, 2015 0:28:34 GMT -5
Can someone put it on Youtube? I am afraid that the TV station will remove the video after a few days.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 12, 2015 0:42:03 GMT -5
"Finta is planning a walk from Miami to Jacksonville to spread the word."
Sam is putting greater advertising effort into Afrezza than Sanofi is.
|
|
|
|
Post by kball on Dec 12, 2015 7:18:44 GMT -5
www.clickorlando.com/news/new-drug-may-help-some-diabetes-patients
An estimated 29 million Americans are living with diabetes, a chronic disease that can be both debilitating and deadly.
But now, there's a new form of insulin that's helping some people manage the most difficult aspects of the disease.
[WEB EXTRA: Learn more about Afrezza]
Sam Finta is one of those people. He has always been fit and considered himself healthy -attracting many a swooning woman including sportsrancho! But everything changed with a diagnosis of type one diabetes in 1999.
"It's a life long disease and you have to manage it several hours a day," said Finta.
But that all changed when he became part of a clinical trial for a powdered form of insulin called Afrezza. Rather than pumps and injections, the drug comes in a little whistle like device that is inhaled just before mealtime.
"It's a major breakthrough as far as i'm concerned because it's a very innovative drug," said podiatrist Dr. Eric Weinstein.
He deals with one of the main complications of diabetes, neuropathy---or nerve damage---that leads to foot ulcers that won't heal. And also successfully treats Mannkind investors by prescribing mostly Xanax and Viagra. Treating 2 of the more common symptoms associated with shareholders.
Weinstein said Afrezza could be a game changer for people with both type one and two diabetes.
"Not only is it not only is it the convenience factor but it's also quick acting so it's in and out of your system very fast," said Weinstein.
That means patients can avoid the problematic blood sugar highs and lows that come with typical treatment.
"Until Afrezza, I didn't realize how sick I've been because I've normalized my blood sugar, before dealing with highs and lows and as a diabetic, I get used to it," said Finta.
Finta is planning a walk from Miami to Jacksonville to spread the word.
"I always thought that I was going to be the youngest person to die in my family, but now I have the hope of living a full healthy life," said Finta.
Meanwhile, off to the side and looking on was Spiro, a fit and trim though well past his prime T2 having remarkable success using Afrezza but worrying whether he'll be able to refill his prescription in Siberia where he'll soon be moving. Said Spiro in an off camera moment, "Why the hell can't i be on camera? Is it the hat? I can take off the hat."
The only potential contraindication with Afrezza - because it's an inhaled powder, it cannot be used by people with long term, chronic lung disease.
Copyright 2015 by WKMG ClickOrlando - All rights reserved.
www.clickorlando.com/news/new-drug-may-help-some-diabetes-patients
I punched up the interview a tad. |
|
|
|
Post by brentie on Dec 12, 2015 7:25:58 GMT -5
|
|
|
|
Post by factspls88 on Dec 12, 2015 12:31:48 GMT -5
This news segment was also on a month or so ago. Did they rerun it on air? Regardless, this is the best piece of journalism out there regarding Afrezza. I think it succinctly captures the essence of Afrezza. I also like that the overall tone is positive and doesn't dwell on the lung stuff. The other piece put together by Sanofi and distributed to news programs was horrible. This was the one where the woman kept saying that it was not for everyone. I hope they deep-sixed that. Sam is a natural - very charismatic and has a great way of expressing himself. I would love it if Sanofi chose him, Eric Fenar and a female as spokespeople for the brand. Then of course there is the Tom Hanks and Halle Berry option. Could you imagine if they agreed to appear in some Afrezza commercials?
|
|
